An opinion and practice survey on the structure and management of data and safety monitoring boards.

There is little to no empirical data available on how data and safety monitoring boards (DSMBs) are structured and how they operate. The purpose of this study was to provide data on this. To accomplish this goal, we administered a random survey on current structure and management practices and opinions as reported by principal investigators (PIs) and biostatisticians.

The CREATE Act: increasing costs associated with the biotech industry?

A new law intended to promote collaborative research may end up costing the biotech industry more and inhibiting innovation.